Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors
作者:Harun Uslu、Derya Osmaniye、Begüm Nurpelin Sağlik、Serkan Levent、Yusuf Özkay、Kadriye Benkli、Zafer Asım Kaplancikli
DOI:10.1016/j.bioorg.2021.105430
日期:2021.12
Monoamine oxidases (MAOs) have become promising drug targets for the development of central nervous system agents. In recent research, it was shown that numerous piperazine derivatives exhibit hMAO inhibitory activity. Therefore, in this study, a novel series of 1,2,4-triazole-piperazine derivatives (5a-j) were designed, synthesized, characterized, and screened for their hMAO-A and hMAO-B inhibitory
单胺氧化酶 (MAO) 已成为开发中枢神经系统药物的有希望的药物靶点。最近的研究表明,许多哌嗪衍生物表现出h MAO 抑制活性。因此,在本研究中,设计、合成、表征和筛选了一系列新型 1,2,4-三唑-哌嗪衍生物 ( 5a - j ) 的h MAO-A 和h MAO-B 抑制活性。当检查 ADME 预测时,可以看出所有合成化合物的药代动力学曲线都是合适的。化合物5a、5b、5c和5e,与 H、F、Cl 和 NO苯环4位上的2个基团分别显示出重要的MAO-A抑制活性。发现化合物5c是合成化合物中最有效的试剂,其对 MAO-A 酶的 IC 50值为 0.070 ± 0.002 µM。合成的化合物似乎支持其他研究的结果,以设计 MAO 抑制剂以获得更合适的药物,特别是针对抑郁症和焦虑症等神经系统疾病。